MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 92 filers reported holding MERUS N V in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,601,975 | -10.4% | 746,479 | 0.0% | 1.17% | -0.4% |
| Q2 2023 | $19,654,792 | +43.1% | 746,479 | 0.0% | 1.17% | +18.1% |
| Q1 2023 | $13,735,214 | +18.9% | 746,479 | 0.0% | 0.99% | +38.4% |
| Q4 2022 | $11,548,030 | -22.8% | 746,479 | 0.0% | 0.72% | -37.6% |
| Q3 2022 | $14,952,000 | -2.0% | 746,479 | +10.8% | 1.15% | -20.1% |
| Q2 2022 | $15,259,000 | -8.2% | 673,979 | +7.2% | 1.44% | +1.6% |
| Q1 2022 | $16,630,000 | – | 628,979 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |